Quantitative multi-gene expression profiling of primary prostate cancer

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Uta Schmidt - , Department of Urology (Author)
  • Susanne Fuessel - , Department of Urology (Author)
  • Rainer Koch - , Institute for Medical Informatics and Biometry (Author)
  • Gustavo B. Baretton - , Institute of Pathology (Author)
  • Andrea Lohse - , Department of Urology (Author)
  • Silke Tomasetti - , Department of Urology (Author)
  • Susanne Unversucht - , Department of Urology (Author)
  • Michael Froehner - , Department of Urology (Author)
  • Manfred P. Wirth - , Department of Urology (Author)
  • Axel Meye - , Department of Urology (Author)

Abstract

BACKGROUND. This study describes the evaluation of the expression patterns of prostate-related transcripts in 106 matched prostate tissues from prostatectomies as predictors for prostate cancer (PCa). METHODS. Quantitative PCR (QPCR) assays with site-specific hybridization probes were established for four housekeeping genes (GAPDH, HPRT, PBGD, TBP) and nine prostate-related genes (AibZIP, D-GPCR, EZH2, PCA3, PDEF, prostein, PSA, PSCA, TRPM8). RESULTS. The relative mRNA expression levels of AibZIP, D-GPCR, EZH2, PCA3, PDEF, PSA, TRPM8 (all P < 0.001) and prostein (P = 0.019) normalized to the TBP reference gene were significantly higher in malignant compared to non-malignant prostate tissues. Employing receiver-operating characteristic (ROC) analyses, PCA3 was the best single tumor marker with the highest area-under-the-curve (AUC = 0.85). A multivariate logit model for the predictability of the tumor was developed, which employed the relative expression levels of EZH2, PCA3, prostein, and TRPM8 and yielded an AUC of 0.90. CONCLUSIONS. The transcript marker PCA3 is a powerful predictor of primary PCa but the inclusion of EZH2, prostein, and TRPM8 adds even more to the diagnostic power. The finding of a significantly higher mRNA expression of three different genes (prostein, PSA, TKPM8) in organ-confined tumors compared to non-organ-confined tumors as well as the multi-marker PCa prediction model developed in the retrospective model system on prostatectomies could be of clinical importance for diagnostic purposes, and should be verified in diagnostic biopsies.

Details

Original languageEnglish
Pages (from-to)1521-1534
Number of pages14
JournalProstate
Volume66
Issue number14
Publication statusPublished - 1 Oct 2006
Peer-reviewedYes

External IDs

PubMed 16921506

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • Expression patterns, LightCycler technology, Molecular tumor marker, Primary prostate carcinoma, Quantitative real-time PCR